State Street Corporation 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-09 08:08 am Purchase | 2025-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 4,596,552 5.300% | 825,726 (+21.90%) | Filing |
| 2024-10-18 11:49 am Sale | 2024-09-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 3,770,826 4.400% | -1,245,398 (-24.83%) | Filing |
| 2024-01-25 11:20 am Purchase | 2023-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 5,016,224 5.910% | 1,367,761 (+37.49%) | Filing |
| 2023-02-06 2:46 pm Purchase | 2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX | STATE STREET CORP STT | 3,648,463 5.360% | 3,648,463 (New Position) | Filing |